These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34181952)

  • 21. Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease-Associated Pulmonary Hypertension.
    Daly CM; Griffiths M; Simpson CE; Yang J; Damico RL; Vaidya RD; Williams M; Brandal S; Jone PN; Polsen C; Ivy DD; Austin ED; Nichols WC; Pauciulo MW; Lutz K; Nies MK; Rosenzweig EB; Hirsch R; Yung D; Everett AD
    J Am Heart Assoc; 2021 Oct; 10(20):e021409. PubMed ID: 34622662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
    Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS
    J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Epicardial Adipose Tissue on Right Cardiac Function and Prognosis in Pulmonary Arterial Hypertension.
    Chen Y; Li J; Li F; Chen Z; Chen Z; Luo J; Qiu H; Chen W; Hu J; Luo X; Tan Y; Rathinasabapathy A; Chen J; Li J
    Chest; 2024 May; 165(5):1211-1223. PubMed ID: 38040053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis.
    Guyot N; Butler MW; McNally P; Weldon S; Greene CM; Levine RL; O'Neill SJ; Taggart CC; McElvaney NG
    J Biol Chem; 2008 Nov; 283(47):32377-85. PubMed ID: 18799464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Value of Plasma Immunoglobulin G N-Glycome Traits in Pulmonary Arterial Hypertension.
    Zhang ZJ; Liu C; Ma JL; Ma JS; Wang J; Li RN; Lu D; Zhou YP; Lian TY; Zhang SJ; Li JH; Wang L; Sun K; Cheng CY; Wu WH; Jiang X; Jing ZC
    J Am Coll Cardiol; 2024 Sep; 84(12):1092-1103. PubMed ID: 39260931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutrophil elastase is produced by pulmonary artery smooth muscle cells and is linked to neointimal lesions.
    Kim YM; Haghighat L; Spiekerkoetter E; Sawada H; Alvira CM; Wang L; Acharya S; Rodriguez-Colon G; Orton A; Zhao M; Rabinovitch M
    Am J Pathol; 2011 Sep; 179(3):1560-72. PubMed ID: 21763677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk Reduction and Right Heart Reverse Remodeling by Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension.
    D'Alto M; Badagliacca R; Argiento P; Romeo E; Farro A; Papa S; Sarubbi B; Russo MG; Vizza CD; Golino P; Naeije R
    Chest; 2020 Feb; 157(2):376-383. PubMed ID: 31563498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular sources of interleukin-6 and associations with clinical phenotypes and outcomes in pulmonary arterial hypertension.
    Simpson CE; Chen JY; Damico RL; Hassoun PM; Martin LJ; Yang J; Nies M; Griffiths M; Vaidya RD; Brandal S; Pauciulo MW; Lutz KA; Coleman AW; Austin ED; Ivy DD; Nichols WC; Everett AD
    Eur Respir J; 2020 Apr; 55(4):. PubMed ID: 32029443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 30. Circulating levels of copeptin predict outcome in patients with pulmonary arterial hypertension.
    Nickel NP; Lichtinghagen R; Golpon H; Olsson KM; Brand K; Welte T; Hoeper MM
    Respir Res; 2013 Nov; 14(1):130. PubMed ID: 24251953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma markers in pulmonary hypertension subgroups correlate with patient survival.
    Koudstaal T; van Uden D; van Hulst JAC; Heukels P; Bergen IM; Geenen LW; Baggen VJM; van den Bosch AE; van den Toorn LM; Chandoesing PP; Kool M; Boersma E; Hendriks RW; Boomars KA
    Respir Res; 2021 May; 22(1):137. PubMed ID: 33947407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender Difference in Damage-Mediated Signaling Contributes to Pulmonary Arterial Hypertension.
    Rafikov R; Nair V; Sinari S; Babu H; Sullivan JC; Yuan JX; Desai AA; Rafikova O
    Antioxid Redox Signal; 2019 Nov; 31(13):917-932. PubMed ID: 30652485
    [No Abstract]   [Full Text] [Related]  

  • 33. Trans-right ventricle and transpulmonary metabolite gradients in human pulmonary arterial hypertension.
    Chouvarine P; Giera M; Kastenmüller G; Artati A; Adamski J; Bertram H; Hansmann G
    Heart; 2020 Sep; 106(17):1332-1341. PubMed ID: 32079620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in main pulmonary artery diameter during follow-up have prognostic implications in pulmonary arterial hypertension.
    Tonelli AR; Johnson S; Alkukhun L; Yadav R; Dweik RA
    Respirology; 2017 Nov; 22(8):1649-1655. PubMed ID: 28514116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophil activation, acute lung injury and disease severity in Plasmodium knowlesi malaria.
    Tan AF; Sakam SSB; Piera K; Rajahram GS; William T; Barber BE; Anstey NM; Grigg MJ; Kho S
    PLoS Negl Trop Dis; 2024 Aug; 18(8):e0012424. PubMed ID: 39150978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of the REVEAL Prognostic Equation and Risk Score Calculator in Incident Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
    Mullin CJ; Khair RM; Damico RL; Kolb TM; Hummers LK; Hassoun PM; Steen VD; Mathai SC;
    Arthritis Rheumatol; 2019 Oct; 71(10):1691-1700. PubMed ID: 31066998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
    Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Extracellular Vesicles in Pulmonary Arterial Hypertension: Modulation of Pulmonary Endothelial Function and Angiogenesis.
    Khandagale A; Åberg M; Wikström G; Bergström Lind S; Shevchenko G; Björklund E; Siegbahn A; Christersson C
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2293-2309. PubMed ID: 32757648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elafin Treatment Rescues EGFR-Klf4 Signaling and Lung Cell Survival in Ventilated Newborn Mice.
    Alejandre Alcazar MA; Kaschwich M; Ertsey R; Preuss S; Milla C; Mujahid S; Masumi J; Khan S; Mokres LM; Tian L; Mohr J; Hirani DV; Rabinovitch M; Bland RD
    Am J Respir Cell Mol Biol; 2018 Nov; 59(5):623-634. PubMed ID: 29894205
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.